APO Research
Talk to an analyst

APO RESEARCH · REPORT

Liposomes Drug Delivery

Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only.

In a liposome drug product, the drug substance is contained in liposomes. Typically, water soluble drugs are contained in the aqueous compartment(s) and hydrophobic drugs are contained in the lipid layer(s) of the liposomes. Release of drugs from liposome formulations can be modified by the presence of polyethylene glycol and/or cholesterol or other potential additives in the liposome.

Selected research

Market Analysis & Forecast

Global Liposomes Drug Delivery Market Analysis and Forecast 2026-2032

21 December 2025196 pages

Choose your research edition.

Industry ResearchLiposomes Drug Delivery Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Liposomes Drug Delivery Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Liposomes Drug Delivery Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Liposomes Drug Delivery Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Liposomes Drug Delivery Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only.

In a liposome drug product, the drug substance is contained in liposomes. Typically, water soluble drugs are contained in the aqueous compartment(s) and hydrophobic drugs are contained in the lipid layer(s) of the liposomes. Release of drugs from liposome formulations can be modified by the presence of polyethylene glycol and/or cholesterol or other potential additives in the liposome.

North America dominated the market with market share of 44% due to the high medical level. Following North America, Europe is the second largest market with market share of 36%. Asian Pacific regions are the third largest market with developed countries like Japan and many developing countries like China. Its market share is about 12%.

Read the full market overview

Johnson & Johnson, Gilead Sciences, Pacira, Sun Pharmaceutical, Luye Pharma and Sigma-Tau Group are the top 6 players of Liposomes Drug Delivery, with about 77% market shares.

This report presents an overview of global market for Liposomes Drug Delivery, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Liposomes Drug Delivery, also provides the sales of main regions and countries. Of the upcoming market potential for Liposomes Drug Delivery, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Liposomes Drug Delivery sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Liposomes Drug Delivery market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Liposomes Drug Delivery sales, projected growth trends, production technology, application and end-user industry.

Liposomes Drug Delivery Segment by Company

Johnson & Johnson

Gilead Sciences

Pacira

Sun Pharmaceutical

Luye Pharma

Sigma-Tau Group

Fudan-Zhangjiang

Teva Pharmaceutical

CSPC

Novartis

Kingond Pharm

Spectrum Pharmaceuticals

Shanghai New Asia

Liposomes Drug Delivery Segment by Type

Liposomal Doxorubicin

Liposomal Amphoteracin B

Liposomal Paclitaxel

Others

Liposomes Drug Delivery Segment by Application

Fungal Infection Therapy

Cancer & Tumor Therapy

Others

Liposomes Drug Delivery Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Liposomes Drug Delivery market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Liposomes Drug Delivery and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Liposomes Drug Delivery.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Liposomes Drug Delivery in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Liposomes Drug Delivery manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Liposomes Drug Delivery sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Liposomes Drug Delivery Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Liposomal Doxorubicin Major Manufacturers Table 3. Liposomal Amphoteracin B Major Manufacturers Table 4. Liposomal Paclitaxel Major Manufacturers Table 5. Others Major Manufacturers Table 6. Global Liposomes Drug Delivery Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Fungal Infection Therapy Major Manufacturers Table 8. Cancer & Tumor Therapy Major Manufacturers Table 9. Others Major Manufacturers Table 10. Liposomes Drug Delivery Industry Trends Table 11. Liposomes Drug Delivery Industry Drivers Table 12. Liposomes Drug Delivery Industry Opportunities and Challenges Table 13. Liposomes Drug Delivery Industry Restraints Table 14. Global Liposomes Drug Delivery Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Liposomes Drug Delivery Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Liposomes Drug Delivery Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Liposomes Drug Delivery Revenue Market Share by Region (2021-2026) Table 18. Global Liposomes Drug Delivery Revenue Market Share by Region (2027-2032) Table 19. Global Liposomes Drug Delivery Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Vials) Table 20. Global Liposomes Drug Delivery Sales by Region (2021-2026) & (K Vials) Table 21. Global Liposomes Drug Delivery Sales by Region (2027-2032) & (K Vials) Table 22. Global Liposomes Drug Delivery Sales Market Share by Region (2021-2026) Table 23. Global Liposomes Drug Delivery Sales Market Share by Region (2027-2032) Table 24. Global Liposomes Drug Delivery Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Liposomes Drug Delivery Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Liposomes Drug Delivery Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Liposomes Drug Delivery Sales Market Share by Manufacturers (2021-2026) Table 28. Global Liposomes Drug Delivery Sales Price (USD/Vial) of Manufacturers (2021-2026) Table 29. Global Liposomes Drug Delivery Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Liposomes Drug Delivery Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Liposomes Drug Delivery Manufacturers, Product Type & Application Table 32. Global Liposomes Drug Delivery Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Liposomes Drug Delivery by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Liposomes Drug Delivery Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Liposomes Drug Delivery Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Liposomes Drug Delivery Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Liposomes Drug Delivery Revenue Market Share by Type (2021-2026) Table 39. Global Liposomes Drug Delivery Revenue Market Share by Type (2027-2032) Table 40. Global Liposomes Drug Delivery Sales by Type 2021 VS 2025 VS 2032 (K Vials) Table 41. Global Liposomes Drug Delivery Sales by Type (2021-2026) & (K Vials) Table 42. Global Liposomes Drug Delivery Sales by Type (2027-2032) & (K Vials) Table 43. Global Liposomes Drug Delivery Sales Market Share by Type (2021-2026) Table 44. Global Liposomes Drug Delivery Sales Market Share by Type (2027-2032) Table 45. Global Liposomes Drug Delivery Price by Type (2021-2026) & (USD/Vial) Table 46. Global Liposomes Drug Delivery Price by Type (2027-2032) & (USD/Vial) Table 47. Global Liposomes Drug Delivery Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Liposomes Drug Delivery Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Liposomes Drug Delivery Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Liposomes Drug Delivery Revenue Market Share by Application (2021-2026) Table 51. Global Liposomes Drug Delivery Revenue Market Share by Application (2027-2032) Table 52. Global Liposomes Drug Delivery Sales by Application 2021 VS 2025 VS 2032 (K Vials) Table 53. Global Liposomes Drug Delivery Sales by Application (2021-2026) & (K Vials) Table 54. Global Liposomes Drug Delivery Sales by Application (2027-2032) & (K Vials) Table 55. Global Liposomes Drug Delivery Sales Market Share by Application (2021-2026) Table 56. Global Liposomes Drug Delivery Sales Market Share by Application (2027-2032) Table 57. Global Liposomes Drug Delivery Price by Application (2021-2026) & (USD/Vial) Table 58. Global Liposomes Drug Delivery Price by Application (2027-2032) & (USD/Vial) Table 59. Johnson & Johnson Company Information Table 60. Johnson & Johnson Business Overview Table 61. Johnson & Johnson Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2021-2026) Table 62. Johnson & Johnson Liposomes Drug Delivery Product Portfolio Table 63. Johnson & Johnson Recent Development Table 64. Gilead Sciences Company Information Table 65. Gilead Sciences Business Overview Table 66. Gilead Sciences Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2021-2026) Table 67. Gilead Sciences Liposomes Drug Delivery Product Portfolio Table 68. Gilead Sciences Recent Development Table 69. Pacira Company Information Table 70. Pacira Business Overview Table 71. Pacira Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2021-2026) Table 72. Pacira Liposomes Drug Delivery Product Portfolio Table 73. Pacira Recent Development Table 74. Sun Pharmaceutical Company Information Table 75. Sun Pharmaceutical Business Overview Table 76. Sun Pharmaceutical Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2021-2026) Table 77. Sun Pharmaceutical Liposomes Drug Delivery Product Portfolio Table 78. Sun Pharmaceutical Recent Development Table 79. Luye Pharma Company Information Table 80. Luye Pharma Business Overview Table 81. Luye Pharma Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2021-2026) Table 82. Luye Pharma Liposomes Drug Delivery Product Portfolio Table 83. Luye Pharma Recent Development Table 84. Sigma-Tau Group Company Information Table 85. Sigma-Tau Group Business Overview Table 86. Sigma-Tau Group Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2021-2026) Table 87. Sigma-Tau Group Liposomes Drug Delivery Product Portfolio Table 88. Sigma-Tau Group Recent Development Table 89. Fudan-Zhangjiang Company Information Table 90. Fudan-Zhangjiang Business Overview Table 91. Fudan-Zhangjiang Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2021-2026) Table 92. Fudan-Zhangjiang Liposomes Drug Delivery Product Portfolio Table 93. Fudan-Zhangjiang Recent Development Table 94. Teva Pharmaceutical Company Information Table 95. Teva Pharmaceutical Business Overview Table 96. Teva Pharmaceutical Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2021-2026) Table 97. Teva Pharmaceutical Liposomes Drug Delivery Product Portfolio Table 98. Teva Pharmaceutical Recent Development Table 99. CSPC Company Information Table 100. CSPC Business Overview Table 101. CSPC Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2021-2026) Table 102. CSPC Liposomes Drug Delivery Product Portfolio Table 103. CSPC Recent Development Table 104. Novartis Company Information Table 105. Novartis Business Overview Table 106. Novartis Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2021-2026) Table 107. Novartis Liposomes Drug Delivery Product Portfolio Table 108. Novartis Recent Development Table 109. Kingond Pharm Company Information Table 110. Kingond Pharm Business Overview Table 111. Kingond Pharm Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2021-2026) Table 112. Kingond Pharm Liposomes Drug Delivery Product Portfolio Table 113. Kingond Pharm Recent Development Table 114. Spectrum Pharmaceuticals Company Information Table 115. Spectrum Pharmaceuticals Business Overview Table 116. Spectrum Pharmaceuticals Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2021-2026) Table 117. Spectrum Pharmaceuticals Liposomes Drug Delivery Product Portfolio Table 118. Spectrum Pharmaceuticals Recent Development Table 119. Shanghai New Asia Company Information Table 120. Shanghai New Asia Business Overview Table 121. Shanghai New Asia Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2021-2026) Table 122. Shanghai New Asia Liposomes Drug Delivery Product Portfolio Table 123. Shanghai New Asia Recent Development Table 124. North America Liposomes Drug Delivery Revenue by Type (2021-2026) & (US$ Million) Table 125. North America Liposomes Drug Delivery Revenue by Type (2027-2032) & (US$ Million) Table 126. North America Liposomes Drug Delivery Sales by Type (2021-2026) & (K Vials) Table 127. North America Liposomes Drug Delivery Sales by Type (2027-2032) & (K Vials) Table 128. North America Liposomes Drug Delivery Sales Price by Type (2021-2026) & (USD/Vial) Table 129. North America Liposomes Drug Delivery Sales Price by Type (2027-2032) & (USD/Vial) Table 130. North America Liposomes Drug Delivery Revenue by Application (2021-2026) & (US$ Million) Table 131. North America Liposomes Drug Delivery Revenue by Application (2027-2032) & (US$ Million) Table 132. North America Liposomes Drug Delivery Sales by Application (2021-2026) & (K Vials) Table 133. North America Liposomes Drug Delivery Sales by Application (2027-2032) & (K Vials) Table 134. North America Liposomes Drug Delivery Sales Price by Application (2021-2026) & (USD/Vial) Table 135. North America Liposomes Drug Delivery Sales Price by Application (2027-2032) & (USD/Vial) Table 136. North America Liposomes Drug Delivery Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 137. North America Liposomes Drug Delivery Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 138. North America Liposomes Drug Delivery Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 139. North America Liposomes Drug Delivery Sales by Country (2021 VS 2025 VS 2032) & (K Vials) Table 140. North America Liposomes Drug Delivery Sales by Country (2021-2026) & (K Vials) Table 141. North America Liposomes Drug Delivery Sales by Country (2027-2032) & (K Vials) Table 142. North America Liposomes Drug Delivery Sales Price by Country (2021-2026) & (USD/Vial) Table 143. North America Liposomes Drug Delivery Sales Price by Country (2027-2032) & (USD/Vial) Table 144. United States Liposomes Drug Delivery Revenue (2021-2032) & (US$ Million) Table 145. Canada Liposomes Drug Delivery Revenue (2021-2032) & (US$ Million) Table 146. Mexico Liposomes Drug Delivery Revenue (2021-2032) & (US$ Million) Table 147. Europe Liposomes Drug Delivery Revenue by Type (2021-2026) & (US$ Million) Table 148. Europe Liposomes Drug Delivery Revenue by Type (2027-2032) & (US$ Million) Table 149. Europe Liposomes Drug Delivery Sales by Type (2021-2026) & (K Vials) Table 150. Europe Liposomes Drug Delivery Sales by Type (2027-2032) & (K Vials) Table 151. Europe Liposomes Drug Delivery Sales Price by Type (2021-2026) & (USD/Vial) Table 152. Europe Liposomes Drug Delivery Sales Price by Type (2027-2032) & (USD/Vial) Table 153. Europe Liposomes Drug Delivery Revenue by Application (2021-2026) & (US$ Million) Table 154. Europe Liposomes Drug Delivery Revenue by Application (2027-2032) & (US$ Million) Table 155. Europe Liposomes Drug Delivery Sales by Application (2021-2026) & (K Vials) Table 156. Europe Liposomes Drug Delivery Sales by Application (2027-2032) & (K Vials) Table 157. Europe Liposomes Drug Delivery Sales Price by Application (2021-2026) & (USD/Vial) Table 158. Europe Liposomes Drug Delivery Sales Price by Application (2027-2032) & (USD/Vial) Table 159. Europe Liposomes Drug Delivery Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 160. Europe Liposomes Drug Delivery Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 161. Europe Liposomes Drug Delivery Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 162. Europe Liposomes Drug Delivery Sales by Country (2021 VS 2025 VS 2032) & (K Vials) Table 163. Europe Liposomes Drug Delivery Sales by Country (2021-2026) & (K Vials) Table 164. Europe Liposomes Drug Delivery Sales by Country (2027-2032) & (K Vials) Table 165. Europe Liposomes Drug Delivery Sales Price by Country (2021-2026) & (USD/Vial) Table 166. Europe Liposomes Drug Delivery Sales Price by Country (2027-2032) & (USD/Vial) Table 167. Germany Liposomes Drug Delivery Revenue (2021-2032) & (US$ Million) Table 168. France Liposomes Drug Delivery Revenue (2021-2032) & (US$ Million) Table 169. U.K. Liposomes Drug Delivery Revenue (2021-2032) & (US$ Million) Table 170. Italy Liposomes Drug Delivery Revenue (2021-2032) & (US$ Million) Table 171. Russia Liposomes Drug Delivery Revenue (2021-2032) & (US$ Million) Table 172. Spain Liposomes Drug Delivery Revenue (2021-2032) & (US$ Million) Table 173. Netherlands Liposomes Drug Delivery Revenue (2021-2032) & (US$ Million) Table 174. Switzerland Liposomes Drug Delivery Revenue (2021-2032) & (US$ Million) Table 175. Sweden Liposomes Drug Delivery Revenue (2021-2032) & (US$ Million) Table 176. Poland Liposomes Drug Delivery Revenue (2021-2032) & (US$ Million) Table 177. China Liposomes Drug Delivery Revenue by Type (2021-2026) & (US$ Million) Table 178. China Liposomes Drug Delivery Revenue by Type (2027-2032) & (US$ Million) Table 179. China Liposomes Drug Delivery Sales by Type (2021-2026) & (K Vials) Table 180. China Liposomes Drug Delivery Sales by Type (2027-2032) & (K Vials) Table 181. China Liposomes Drug Delivery Sales Price by Type (2021-2026) & (USD/Vial) Table 182. China Liposomes Drug Delivery Sales Price by Type (2027-2032) & (USD/Vial) Table 183. China Liposomes Drug Delivery Revenue by Application (2021-2026) & (US$ Million) Table 184. China Liposomes Drug Delivery Revenue by Application (2027-2032) & (US$ Million) Table 185. China Liposomes Drug Delivery Sales by Application (2021-2026) & (K Vials) Table 186. China Liposomes Drug Delivery Sales by Application (2027-2032) & (K Vials) Table 187. China Liposomes Drug Delivery Sales Price by Application (2021-2026) & (USD/Vial) Table 188. China Liposomes Drug Delivery Sales Price by Application (2027-2032) & (USD/Vial) Table 189. Asia Liposomes Drug Delivery Revenue by Type (2021-2026) & (US$ Million) Table 190. Asia Liposomes Drug Delivery Revenue by Type (2027-2032) & (US$ Million) Table 191. Asia Liposomes Drug Delivery Sales by Type (2021-2026) & (K Vials) Table 192. Asia Liposomes Drug Delivery Sales by Type (2027-2032) & (K Vials) Table 193. Asia Liposomes Drug Delivery Sales Price by Type (2021-2026) & (USD/Vial) Table 194. Asia Liposomes Drug Delivery Sales Price by Type (2027-2032) & (USD/Vial) Table 195. Asia Liposomes Drug Delivery Revenue by Application (2021-2026) & (US$ Million) Table 196. Asia Liposomes Drug Delivery Revenue by Application (2027-2032) & (US$ Million) Table 197. Asia Liposomes Drug Delivery Sales by Application (2021-2026) & (K Vials) Table 198. Asia Liposomes Drug Delivery Sales by Application (2027-2032) & (K Vials) Table 199. Asia Liposomes Drug Delivery Sales Price by Application (2021-2026) & (USD/Vial) Table 200. Asia Liposomes Drug Delivery Sales Price by Application (2027-2032) & (USD/Vial) Table 201. Asia Liposomes Drug Delivery Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 202. Asia Liposomes Drug Delivery Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 203. Asia Liposomes Drug Delivery Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 204. Asia Liposomes Drug Delivery Sales by Country (2021 VS 2025 VS 2032) & (K Vials) Table 205. Asia Liposomes Drug Delivery Sales by Country (2021-2026) & (K Vials) Table 206. Asia Liposomes Drug Delivery Sales by Country (2027-2032) & (K Vials) Table 207. Asia Liposomes Drug Delivery Sales Price by Country (2021-2026) & (USD/Vial) Table 208. Asia Liposomes Drug Delivery Sales Price by Country (2027-2032) & (USD/Vial) Table 209. Japan Liposomes Drug Delivery Revenue (2021-2032) & (US$ Million) Table 210. South Korea Liposomes Drug Delivery Revenue (2021-2032) & (US$ Million) Table 211. India Liposomes Drug Delivery Revenue (2021-2032) & (US$ Million) Table 212. Australia Liposomes Drug Delivery Revenue (2021-2032) & (US$ Million) Table 213. Taiwan Liposomes Drug Delivery Revenue (2021-2032) & (US$ Million) Table 214. Southeast Asia Liposomes Drug Delivery Revenue (2021-2032) & (US$ Million) Table 215. SAMEA Liposomes Drug Delivery Revenue by Type (2021-2026) & (US$ Million) Table 216. SAMEA Liposomes Drug Delivery Revenue by Type (2027-2032) & (US$ Million) Table 217. SAMEA Liposomes Drug Delivery Sales by Type (2021-2026) & (K Vials) Table 218. SAMEA Liposomes Drug Delivery Sales by Type (2027-2032) & (K Vials) Table 219. SAMEA Liposomes Drug Delivery Sales Price by Type (2021-2026) & (USD/Vial) Table 220. SAMEA Liposomes Drug Delivery Sales Price by Type (2027-2032) & (USD/Vial) Table 221. SAMEA Liposomes Drug Delivery Revenue by Application (2021-2026) & (US$ Million) Table 222. SAMEA Liposomes Drug Delivery Revenue by Application (2027-2032) & (US$ Million) Table 223. SAMEA Liposomes Drug Delivery Sales by Application (2021-2026) & (K Vials) Table 224. SAMEA Liposomes Drug Delivery Sales by Application (2027-2032) & (K Vials) Table 225. SAMEA Liposomes Drug Delivery Sales Price by Application (2021-2026) & (USD/Vial) Table 226. SAMEA Liposomes Drug Delivery Sales Price by Application (2027-2032) & (USD/Vial) Table 227. SAMEA Liposomes Drug Delivery Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 228. SAMEA Liposomes Drug Delivery Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 229. SAMEA Liposomes Drug Delivery Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 230. SAMEA Liposomes Drug Delivery Sales by Country (2021 VS 2025 VS 2032) & (K Vials) Table 231. SAMEA Liposomes Drug Delivery Sales by Country (2021-2026) & (K Vials) Table 232. SAMEA Liposomes Drug Delivery Sales by Country (2027-2032) & (K Vials) Table 233. SAMEA Liposomes Drug Delivery Sales Price by Country (2021-2026) & (USD/Vial) Table 234. SAMEA Liposomes Drug Delivery Sales Price by Country (2027-2032) & (USD/Vial) Table 235. Brazil Liposomes Drug Delivery Revenue (2021-2032) & (US$ Million) Table 236. Argentina Liposomes Drug Delivery Revenue (2021-2032) & (US$ Million) Table 237. Chile Liposomes Drug Delivery Revenue (2021-2032) & (US$ Million) Table 238. Colombia Liposomes Drug Delivery Revenue (2021-2032) & (US$ Million) Table 239. Peru Liposomes Drug Delivery Revenue (2021-2032) & (US$ Million) Table 240. Saudi Arabia Liposomes Drug Delivery Revenue (2021-2032) & (US$ Million) Table 241. Israel Liposomes Drug Delivery Revenue (2021-2032) & (US$ Million) Table 242. UAE Liposomes Drug Delivery Revenue (2021-2032) & (US$ Million) Table 243. Turkey Liposomes Drug Delivery Revenue (2021-2032) & (US$ Million) Table 244. Iran Liposomes Drug Delivery Revenue (2021-2032) & (US$ Million) Table 245. Egypt Liposomes Drug Delivery Revenue (2021-2032) & (US$ Million) Table 246. Key Raw Materials Table 247. Raw Materials Key Suppliers Table 248. Liposomes Drug Delivery Distributors List Table 249. Liposomes Drug Delivery Customers List Table 250. Research Programs/Design for This Report Table 251. Authors List of This Report Table 252. Secondary Sources Table 253. Primary Sources List of Figures Figure 1. Liposomes Drug Delivery Image Figure 2. Global Liposomes Drug Delivery Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Liposomes Drug Delivery Market Size Share 2021 VS 2025 VS 2032 Figure 4. Liposomal Doxorubicin Image Figure 5. Liposomal Amphoteracin B Image Figure 6. Liposomal Paclitaxel Image Figure 7. Others Image Figure 8. Global Liposomes Drug Delivery Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Liposomes Drug Delivery Market Size Share 2021 VS 2025 VS 2032 Figure 10. Fungal Infection Therapy Image Figure 11. Cancer & Tumor Therapy Image Figure 12. Others Image Figure 13. Global Liposomes Drug Delivery Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Liposomes Drug Delivery Revenue (2021-2032) & (US$ Million) Figure 15. Global Liposomes Drug Delivery Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Liposomes Drug Delivery Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Liposomes Drug Delivery Revenue Market Share by Region (2021-2032) Figure 18. Global Liposomes Drug Delivery Sales (2021-2032) & (K Vials) Figure 19. Global Liposomes Drug Delivery Sales by Region: 2021 VS 2025 VS 2032 (K Vials) Figure 20. Global Liposomes Drug Delivery Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Liposomes Drug Delivery Sales YoY (2021-2032) & (K Vials) Figure 22. Europe Liposomes Drug Delivery Sales YoY (2021-2032) & (K Vials) Figure 23. China Liposomes Drug Delivery Sales YoY (2021-2032) & (K Vials) Figure 24. Asia (Excluding China) Liposomes Drug Delivery Sales YoY (2021-2032) & (K Vials) Figure 25. South America, Middle East and Africa Liposomes Drug Delivery Sales YoY (2021-2032) & (K Vials) Figure 26. Global Liposomes Drug Delivery Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Liposomes Drug Delivery Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Liposomes Drug Delivery Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Liposomes Drug Delivery Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Liposomes Drug Delivery Revenue Market Share by Type (2021-2032) Figure 32. Global Liposomes Drug Delivery Sales by Type (2021 VS 2025 VS 2032) & (K Vials) Figure 33. Global Liposomes Drug Delivery Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Liposomes Drug Delivery Sales Market Share by Type (2021-2032) Figure 35. Global Liposomes Drug Delivery Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Liposomes Drug Delivery Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Liposomes Drug Delivery Revenue Market Share by Application (2021-2032) Figure 38. Global Liposomes Drug Delivery Sales by Application (2021 VS 2025 VS 2032) & (K Vials) Figure 39. Global Liposomes Drug Delivery Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Liposomes Drug Delivery Sales Market Share by Application (2021-2032) Figure 41. North America Liposomes Drug Delivery Revenue Share by Type (2021-2032) Figure 42. North America Liposomes Drug Delivery Sales Share by Type (2021-2032) Figure 43. North America Liposomes Drug Delivery Revenue Share by Application (2021-2032) Figure 44. North America Liposomes Drug Delivery Sales Share by Application (2021-2032) Figure 45. North America Liposomes Drug Delivery Revenue Share by Country (2021-2032) Figure 46. North America Liposomes Drug Delivery Sales Share by Country (2021-2032) Figure 47. Europe Liposomes Drug Delivery Revenue Share by Type (2021-2032) Figure 48. Europe Liposomes Drug Delivery Sales Share by Type (2021-2032) Figure 49. Europe Liposomes Drug Delivery Revenue Share by Application (2021-2032) Figure 50. Europe Liposomes Drug Delivery Sales Share by Application (2021-2032) Figure 51. Europe Liposomes Drug Delivery Revenue Share by Country (2021-2032) Figure 52. Europe Liposomes Drug Delivery Sales Share by Country (2021-2032) Figure 53. China Liposomes Drug Delivery Revenue Share by Type (2021-2032) Figure 54. China Liposomes Drug Delivery Sales Share by Type (2021-2032) Figure 55. China Liposomes Drug Delivery Revenue Share by Application (2021-2032) Figure 56. China Liposomes Drug Delivery Sales Share by Application (2021-2032) Figure 57. Asia Liposomes Drug Delivery Revenue Share by Type (2021-2032) Figure 58. Asia Liposomes Drug Delivery Sales Share by Type (2021-2032) Figure 59. Asia Liposomes Drug Delivery Revenue Share by Application (2021-2032) Figure 60. Asia Liposomes Drug Delivery Sales Share by Application (2021-2032) Figure 61. Asia Liposomes Drug Delivery Revenue Share by Country (2021-2032) Figure 62. Asia Liposomes Drug Delivery Sales Share by Country (2021-2032) Figure 63. SAMEA Liposomes Drug Delivery Revenue Share by Type (2021-2032) Figure 64. SAMEA Liposomes Drug Delivery Sales Share by Type (2021-2032) Figure 65. SAMEA Liposomes Drug Delivery Revenue Share by Application (2021-2032) Figure 66. SAMEA Liposomes Drug Delivery Sales Share by Application (2021-2032) Figure 67. SAMEA Liposomes Drug Delivery Revenue Share by Country (2021-2032) Figure 68. SAMEA Liposomes Drug Delivery Sales Share by Country (2021-2032) Figure 69. Liposomes Drug Delivery Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Liposomes Drug Delivery Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Liposomal Doxorubicin
  • Liposomal Amphoteracin B
  • Liposomal Paclitaxel
  • Others
Applications
  • Fungal Infection Therapy
  • Cancer & Tumor Therapy
  • Others
Companies covered
  • Johnson & Johnson
  • Gilead Sciences
  • Pacira
  • Sun Pharmaceutical
  • Luye Pharma
  • Sigma-Tau Group
  • Fudan-Zhangjiang
  • Teva Pharmaceutical
  • CSPC
  • Novartis
  • Kingond Pharm
  • Spectrum Pharmaceuticals
  • Shanghai New Asia

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Liposomes Drug Delivery Market by Type
  3. 1.2.1 Global Liposomes Drug Delivery Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Liposomal Doxorubicin
  5. 1.2.3 Liposomal Amphoteracin B
  6. 1.2.4 Liposomal Paclitaxel
  7. 1.2.5 Others
  8. 1.3 Liposomes Drug Delivery Market by Application
  9. 1.3.1 Global Liposomes Drug Delivery Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Fungal Infection Therapy
  11. 1.3.3 Cancer & Tumor Therapy
  12. 1.3.4 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Liposomes Drug Delivery Market Dynamics
  1. 2.1 Liposomes Drug Delivery Industry Trends
  2. 2.2 Liposomes Drug Delivery Industry Drivers
  3. 2.3 Liposomes Drug Delivery Industry Opportunities and Challenges
  4. 2.4 Liposomes Drug Delivery Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Liposomes Drug Delivery Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Liposomes Drug Delivery Revenue by Region
  3. 3.2.1 Global Liposomes Drug Delivery Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Liposomes Drug Delivery Revenue by Region (2021-2026)
  5. 3.2.3 Global Liposomes Drug Delivery Revenue by Region (2027-2032)
  6. 3.2.4 Global Liposomes Drug Delivery Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Liposomes Drug Delivery Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Liposomes Drug Delivery Sales by Region
  9. 3.4.1 Global Liposomes Drug Delivery Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Liposomes Drug Delivery Sales by Region (2021-2026)
  11. 3.4.3 Global Liposomes Drug Delivery Sales by Region (2027-2032)
  12. 3.4.4 Global Liposomes Drug Delivery Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Liposomes Drug Delivery Revenue by Manufacturers
  2. 4.1.1 Global Liposomes Drug Delivery Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Liposomes Drug Delivery Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Liposomes Drug Delivery Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Liposomes Drug Delivery Sales by Manufacturers
  6. 4.2.1 Global Liposomes Drug Delivery Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Liposomes Drug Delivery Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Liposomes Drug Delivery Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Liposomes Drug Delivery Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Liposomes Drug Delivery Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Liposomes Drug Delivery Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Liposomes Drug Delivery Manufacturers, Product Type & Application
  13. 4.7 Global Liposomes Drug Delivery Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Liposomes Drug Delivery Market CR5 and HHI
  16. 4.8.2 2025 Liposomes Drug Delivery Tier 1, Tier 2, and Tier 3
5 Liposomes Drug Delivery Market by Type
  1. 5.1 Global Liposomes Drug Delivery Revenue by Type
  2. 5.1.1 Global Liposomes Drug Delivery Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Liposomes Drug Delivery Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Liposomes Drug Delivery Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Liposomes Drug Delivery Sales by Type
  6. 5.2.1 Global Liposomes Drug Delivery Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Liposomes Drug Delivery Sales by Type (2021-2032) & (K Vials)
  8. 5.2.3 Global Liposomes Drug Delivery Sales Market Share by Type (2021-2032)
  9. 5.3 Global Liposomes Drug Delivery Price by Type
6 Liposomes Drug Delivery Market by Application
  1. 6.1 Global Liposomes Drug Delivery Revenue by Application
  2. 6.1.1 Global Liposomes Drug Delivery Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Liposomes Drug Delivery Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Liposomes Drug Delivery Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Liposomes Drug Delivery Sales by Application
  6. 6.2.1 Global Liposomes Drug Delivery Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Liposomes Drug Delivery Sales by Application (2021-2032) & (K Vials)
  8. 6.2.3 Global Liposomes Drug Delivery Sales Market Share by Application (2021-2032)
  9. 6.3 Global Liposomes Drug Delivery Price by Application
7 Company Profiles
  1. 7.1 Johnson & Johnson
  2. 7.1.1 Johnson & Johnson Company Information
  3. 7.1.2 Johnson & Johnson Business Overview
  4. 7.1.3 Johnson & Johnson Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Johnson & Johnson Liposomes Drug Delivery Product Portfolio
  6. 7.1.5 Johnson & Johnson Recent Developments
  7. 7.2 Gilead Sciences
  8. 7.2.1 Gilead Sciences Company Information
  9. 7.2.2 Gilead Sciences Business Overview
  10. 7.2.3 Gilead Sciences Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Gilead Sciences Liposomes Drug Delivery Product Portfolio
  12. 7.2.5 Gilead Sciences Recent Developments
  13. 7.3 Pacira
  14. 7.3.1 Pacira Company Information
  15. 7.3.2 Pacira Business Overview
  16. 7.3.3 Pacira Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Pacira Liposomes Drug Delivery Product Portfolio
  18. 7.3.5 Pacira Recent Developments
  19. 7.4 Sun Pharmaceutical
  20. 7.4.1 Sun Pharmaceutical Company Information
  21. 7.4.2 Sun Pharmaceutical Business Overview
  22. 7.4.3 Sun Pharmaceutical Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Sun Pharmaceutical Liposomes Drug Delivery Product Portfolio
  24. 7.4.5 Sun Pharmaceutical Recent Developments
  25. 7.5 Luye Pharma
  26. 7.5.1 Luye Pharma Company Information
  27. 7.5.2 Luye Pharma Business Overview
  28. 7.5.3 Luye Pharma Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Luye Pharma Liposomes Drug Delivery Product Portfolio
  30. 7.5.5 Luye Pharma Recent Developments
  31. 7.6 Sigma-Tau Group
  32. 7.6.1 Sigma-Tau Group Company Information
  33. 7.6.2 Sigma-Tau Group Business Overview
  34. 7.6.3 Sigma-Tau Group Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Sigma-Tau Group Liposomes Drug Delivery Product Portfolio
  36. 7.6.5 Sigma-Tau Group Recent Developments
  37. 7.7 Fudan-Zhangjiang
  38. 7.7.1 Fudan-Zhangjiang Company Information
  39. 7.7.2 Fudan-Zhangjiang Business Overview
  40. 7.7.3 Fudan-Zhangjiang Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Fudan-Zhangjiang Liposomes Drug Delivery Product Portfolio
  42. 7.7.5 Fudan-Zhangjiang Recent Developments
  43. 7.8 Teva Pharmaceutical
  44. 7.8.1 Teva Pharmaceutical Company Information
  45. 7.8.2 Teva Pharmaceutical Business Overview
  46. 7.8.3 Teva Pharmaceutical Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Teva Pharmaceutical Liposomes Drug Delivery Product Portfolio
  48. 7.8.5 Teva Pharmaceutical Recent Developments
  49. 7.9 CSPC
  50. 7.9.1 CSPC Company Information
  51. 7.9.2 CSPC Business Overview
  52. 7.9.3 CSPC Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 CSPC Liposomes Drug Delivery Product Portfolio
  54. 7.9.5 CSPC Recent Developments
  55. 7.10 Novartis
  56. 7.10.1 Novartis Company Information
  57. 7.10.2 Novartis Business Overview
  58. 7.10.3 Novartis Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Novartis Liposomes Drug Delivery Product Portfolio
  60. 7.10.5 Novartis Recent Developments
  61. 7.11 Kingond Pharm
  62. 7.11.1 Kingond Pharm Company Information
  63. 7.11.2 Kingond Pharm Business Overview
  64. 7.11.3 Kingond Pharm Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Kingond Pharm Liposomes Drug Delivery Product Portfolio
  66. 7.11.5 Kingond Pharm Recent Developments
  67. 7.12 Spectrum Pharmaceuticals
  68. 7.12.1 Spectrum Pharmaceuticals Company Information
  69. 7.12.2 Spectrum Pharmaceuticals Business Overview
  70. 7.12.3 Spectrum Pharmaceuticals Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Spectrum Pharmaceuticals Liposomes Drug Delivery Product Portfolio
  72. 7.12.5 Spectrum Pharmaceuticals Recent Developments
  73. 7.13 Shanghai New Asia
  74. 7.13.1 Shanghai New Asia Company Information
  75. 7.13.2 Shanghai New Asia Business Overview
  76. 7.13.3 Shanghai New Asia Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Shanghai New Asia Liposomes Drug Delivery Product Portfolio
  78. 7.13.5 Shanghai New Asia Recent Developments
8 North America
  1. 8.1 North America Liposomes Drug Delivery Market Size by Type
  2. 8.1.1 North America Liposomes Drug Delivery Revenue by Type (2021-2032)
  3. 8.1.2 North America Liposomes Drug Delivery Sales by Type (2021-2032)
  4. 8.1.3 North America Liposomes Drug Delivery Price by Type (2021-2032)
  5. 8.2 North America Liposomes Drug Delivery Market Size by Application
  6. 8.2.1 North America Liposomes Drug Delivery Revenue by Application (2021-2032)
  7. 8.2.2 North America Liposomes Drug Delivery Sales by Application (2021-2032)
  8. 8.2.3 North America Liposomes Drug Delivery Price by Application (2021-2032)
  9. 8.3 North America Liposomes Drug Delivery Market Size by Country
  10. 8.3.1 North America Liposomes Drug Delivery Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Liposomes Drug Delivery Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Liposomes Drug Delivery Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Liposomes Drug Delivery Market Size by Type
  2. 9.1.1 Europe Liposomes Drug Delivery Revenue by Type (2021-2032)
  3. 9.1.2 Europe Liposomes Drug Delivery Sales by Type (2021-2032)
  4. 9.1.3 Europe Liposomes Drug Delivery Price by Type (2021-2032)
  5. 9.2 Europe Liposomes Drug Delivery Market Size by Application
  6. 9.2.1 Europe Liposomes Drug Delivery Revenue by Application (2021-2032)
  7. 9.2.2 Europe Liposomes Drug Delivery Sales by Application (2021-2032)
  8. 9.2.3 Europe Liposomes Drug Delivery Price by Application (2021-2032)
  9. 9.3 Europe Liposomes Drug Delivery Market Size by Country
  10. 9.3.1 Europe Liposomes Drug Delivery Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Liposomes Drug Delivery Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Liposomes Drug Delivery Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Liposomes Drug Delivery Market Size by Type
  2. 10.1.1 China Liposomes Drug Delivery Revenue by Type (2021-2032)
  3. 10.1.2 China Liposomes Drug Delivery Sales by Type (2021-2032)
  4. 10.1.3 China Liposomes Drug Delivery Price by Type (2021-2032)
  5. 10.2 China Liposomes Drug Delivery Market Size by Application
  6. 10.2.1 China Liposomes Drug Delivery Revenue by Application (2021-2032)
  7. 10.2.2 China Liposomes Drug Delivery Sales by Application (2021-2032)
  8. 10.2.3 China Liposomes Drug Delivery Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Liposomes Drug Delivery Market Size by Type
  2. 11.1.1 Asia Liposomes Drug Delivery Revenue by Type (2021-2032)
  3. 11.1.2 Asia Liposomes Drug Delivery Sales by Type (2021-2032)
  4. 11.1.3 Asia Liposomes Drug Delivery Price by Type (2021-2032)
  5. 11.2 Asia Liposomes Drug Delivery Market Size by Application
  6. 11.2.1 Asia Liposomes Drug Delivery Revenue by Application (2021-2032)
  7. 11.2.2 Asia Liposomes Drug Delivery Sales by Application (2021-2032)
  8. 11.2.3 Asia Liposomes Drug Delivery Price by Application (2021-2032)
  9. 11.3 Asia Liposomes Drug Delivery Market Size by Country
  10. 11.3.1 Asia Liposomes Drug Delivery Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Liposomes Drug Delivery Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Liposomes Drug Delivery Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Liposomes Drug Delivery Market Size by Type
  2. 12.1.1 SAMEA Liposomes Drug Delivery Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Liposomes Drug Delivery Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Liposomes Drug Delivery Price by Type (2021-2032)
  5. 12.2 SAMEA Liposomes Drug Delivery Market Size by Application
  6. 12.2.1 SAMEA Liposomes Drug Delivery Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Liposomes Drug Delivery Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Liposomes Drug Delivery Price by Application (2021-2032)
  9. 12.3 SAMEA Liposomes Drug Delivery Market Size by Country
  10. 12.3.1 SAMEA Liposomes Drug Delivery Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Liposomes Drug Delivery Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Liposomes Drug Delivery Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Liposomes Drug Delivery Value Chain Analysis
  2. 13.1.1 Liposomes Drug Delivery Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Liposomes Drug Delivery Production Mode & Process
  6. 13.2 Liposomes Drug Delivery Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Liposomes Drug Delivery Distributors
  9. 13.2.3 Liposomes Drug Delivery Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst